Circulating Metabolites to Predict Renal Outcomes in CANVAS Type 2 Diabetes Mellitus Population

被引：0

作者：

Darshi, Manjula ^{[1
]}

Tefera, Eshetu ^{[2
]}

Gao, Bin ^{[2
]}

Weidner-Wells, Michele ^{[2
]}

Reilly, Dermot F. ^{[1
]}

Coorey, Craig ^{[3
,4
]}

Tang, Owen ^{[5
,6
,7
,8
]}

Yang, Jean ^{[5
,9
]}

Neal, Bruce ^{[10
]}

Arnott, Clare G. ^{[10
]}

Mahaffey, Kenneth W. ^{[11
]}

Perkovic, Vlado ^{[10
]}

Hansen, Michael K. ^{[2
]}

Ferrannini, Ele ^{[12
]}

Figtree, Gemma ^{[5
,6
,7
,8
]}

机构：

[1] Janssen Res & Dev LLC, Boston, MA USA

[2] Janssen Res & Dev LLC, Spring House, PA USA

[3] Western Sydney Univ, Sch Med, Sydney, NSW, Australia

[4] Royal North Shore Hosp, St Leonards, NSW, Australia

[5] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia

[6] Royal North Shore Hosp, Dept Cardiol, St Leonards, NSW, Australia

[7] Univ Sydney, Kolling Inst Med Res, Cardiovasc Discovery Grp, Sydney, NSW, Australia

[8] Univ Sydney, Fac Med & Hlth, Sydney, NSW, Australia

[9] Univ Sydney, Sch Math & Stat, Sydney, NSW, Australia

[10] UNSW Sydney, George Inst Global Hlth, Sydney, NSW, Australia

[11] Stanford Univ, Sch Med, Dept Med, Stanford Ctr Clin Res, Stanford, CA 94305 USA

[12] CNR, Inst Clin Physiol, Pisa, Italy

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

SA-OR28

引用

页码：47 / 47

页数：1

共 50 条

[41] The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
Carbone, Salvatore
Dixon, Dave L.
CARDIOVASCULAR DIABETOLOGY, 2019, 18 (1)
[42] Canagliflozin and Stroke in Type 2 Diabetes Mellitus Results From the Randomized CANVAS Program Trials
Zhou, Zien
Lindley, Richard I.
Radholm, Karin
Jenkins, Bronwyn
Watson, John
Perkovic, Vlado
Mahaffey, Kenneth W.
de Zeeuw, Dick
Fulcher, Greg
Shaw, Wayne
Oh, Richard
Desai, Mehul
Matthews, David R.
Neal, Bruce
STROKE, 2019, 50 (02) : 396 - 404
[43] The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus
Salvatore Carbone
Dave L. Dixon
Cardiovascular Diabetology, 18
[44] Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Wu, Jiaqiang
Yang, Kangping
Fan, Hancheng
Wei, Meilin
Xiong, Qin
FRONTIERS IN ENDOCRINOLOGY, 2023, 14
[45] Reactive metabolites and antioxidant gene polymorphisms in Type 2 diabetes mellitus
Banerjee, Monisha
Vats, Pushpank
REDOX BIOLOGY, 2014, 2 : 170 - 177
[46] Circulating C5L2 gene polymorphism is associated with type 2 diabetes mellitus in Saudi population
Khalid K. Alharbi
Imran Ali Khan
Rabbani Syed
Molecular Biology Reports, 2013, 40 : 6323 - 6327
[47] Circulating C5L2 gene polymorphism is associated with type 2 diabetes mellitus in Saudi population
Alharbi, Khalid K.
Khan, Imran Ali
Syed, Rabbani
MOLECULAR BIOLOGY REPORTS, 2013, 40 (11) : 6323 - 6327
[48] Circulating progenitor cells in the natural history of type 2 diabetes mellitus
Fadini, G.
de Kreutzenberg, S.
Agostini, C.
Tiengo, A.
Avogaro, A.
DIABETOLOGIA, 2008, 51 : S15 - S15
[49] Circulating adhesion molecules levels in type 2 diabetes mellitus and hypertension
Boulbou, MS
Koukoulis, GN
Makri, ED
Petinaki, EA
Gourgoulianis, KI
Germenis, AE
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2005, 98 (01) : 39 - 44
[50] Circulating follistatin as a novel biomarker of type 2 diabetes mellitus risk
Stella Papachristou
Djordje S. Popovic
Nikolaos Papanas
International Journal of Diabetes in Developing Countries, 2023, 43 : 779 - 780

← 1 2 3 4 5 →